Benzinga | Jan 19, 2022 08:09AM EST

Wells Fargo Downgrades Zimmer Biomet Holdings to Underweight, Lowers Price Target to $124

Wells Fargo analyst Larry Biegelsen downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Underweight and lowers the price target from $170 to $124.